Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and ...
The regulator placed a clinical hold on its Covid-19-influenza combination vaccine after one person reported nerve damage.
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...
The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu ...
Novavax announced that the U.S. Food and Drug Administration has placed a clinical hold on Novavax’s Investigational New Drug ...
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
Roger Song has given his Buy rating due to a combination of factors that, despite current challenges, present potential upside for Novavax. The company is dealing with a clinical hold on its CIC ...
The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.
Novavax Inc. (NASDAQ:NVAX) stock is trading lower on Wednesday. The FDA has placed a clinical hold on Novavax’s ...
Highlights,Novavax faces a clinical hold following the report of motor neuropathy in a trial participant nearly two years ...
Wednesday said the U.S. Food and Drug Administration (FDA) has placed a clinical hold on its COVID-19-Influenza ...
Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined ...